Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders.
about
Cytotoxic T-cell lymphoma presenting as secondary myelofibrosis with high levels of PDGF and TGF-beta.Localisation and distribution of hyaluronan in normal bone marrow matrix: a novel method to evaluate impending fibrosis?Serum hyaluronan and aminoterminal propeptide of type III procollagen: variation with age.Immune thrombocytopenia is associated with persistently deranged fibrosis-related seromarker profiles but low bone marrow fibrosis grades: A 2-year observational study on thrombopoietin receptor agonist treatment.Serum hyaluronan is increased in malignant lymphoma.
P2860
Circulating hyaluronan in the myelofibrosis/osteomyelosclerosis syndrome and other myeloproliferative disorders.
description
1991 nî lūn-bûn
@nan
1991年の論文
@ja
1991年学术文章
@wuu
1991年学术文章
@zh
1991年学术文章
@zh-cn
1991年学术文章
@zh-hans
1991年学术文章
@zh-my
1991年学术文章
@zh-sg
1991年學術文章
@yue
1991年學術文章
@zh-hant
name
Circulating hyaluronan in the ...... myeloproliferative disorders.
@en
Circulating hyaluronan in the ...... myeloproliferative disorders.
@nl
type
label
Circulating hyaluronan in the ...... myeloproliferative disorders.
@en
Circulating hyaluronan in the ...... myeloproliferative disorders.
@nl
prefLabel
Circulating hyaluronan in the ...... myeloproliferative disorders.
@en
Circulating hyaluronan in the ...... myeloproliferative disorders.
@nl
P2093
P356
P1476
Circulating hyaluronan in the ...... myeloproliferative disorders.
@en
P2093
Engström Laurent A
Lindqvist U
P2860
P356
10.1002/AJH.2830360102
P577
1991-01-01T00:00:00Z